In preclinical studies of B cell acute lymphoblastic leukemia (B-ALL), mouse models have limitations related to their small body size, which restricts serial sampling required for integrated assessment of efficacy, safety, and pharmacokinetics (PK) assessments... ...

请注册登录后继续浏览